Company Ampio Pharmaceuticals, Inc.

Equities

AMPE

US03209T3077

Biotechnology & Medical Research

Delayed OTC Markets 11:58:35 2024-04-24 am EDT 5-day change 1st Jan Change
0.285 USD -0.35% Intraday chart for Ampio Pharmaceuticals, Inc. +14.00% -86.10%

Business Summary

Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Number of employees: 6

Managers

Managers TitleAgeSince
Chief Executive Officer 68 21-10-12
Chief Tech/Sci/R&D Officer 70 21-10-12
General Counsel - 13-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 75 11-05-31
Chairman 69 21-10-12
Chief Executive Officer 68 21-10-12
Director/Board Member 57 22-02-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,135,358 1,117,631 ( 98.44 %) 0 98.44 %

Shareholders

NameEquities%Valuation
G1 Execution Services LLC
2.353 %
19,580 2.353 % 18 014 $
HRT Financial LLC
2.159 %
17,962 2.159 % 16 525 $
J. Buchi
0.9477 %
7,885 0.9477 % 7 254 $
7,470 0.8978 % 6 872 $
7,111 0.8547 % 6 542 $
CVA Family Office LLC
0.3785 %
3,149 0.3785 % 2 897 $
Morgan Stanley Capital Services LLC
0.3314 %
2,757 0.3314 % 2 536 $
Tower Research Capital LLC
0.2739 %
2,279 0.2739 % 2 097 $
2,041 0.2453 % 1 878 $
Cypress Capital Management LLC (Wyoming)
0.0561 %
467 0.0561 % 430 $

Company contact information

Ampio Pharmaceuticals, Inc.

9800 Mount Pyramid Court Suite 400

80112, Englewood

+720 437 6500

http://www.ampiopharma.com
address Ampio Pharmaceuticals, Inc.(AMPE)
  1. Stock Market
  2. Equities
  3. AMPE Stock
  4. Company Ampio Pharmaceuticals, Inc.